Overview

AM-101 in the Treatment of Post-Acute Tinnitus 2

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety and local tolerance of repeated treatment with AM-101.
Phase:
Phase 3
Details
Lead Sponsor:
Auris Medical AG